(-0.07%) 5 044.00 points
(-0.03%) 38 457 points
(-0.14%) 17 326 points
(0.21%) $83.02
(-0.34%) $1.785
(-1.26%) $2 316.90
(-1.34%) $26.88
(-1.36%) $918.60
(0.11%) $0.939
(0.18%) $11.01
(0.04%) $0.810
(-0.10%) $93.32
Live Chart Being Loaded With Signals
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases...
Stats | |
---|---|
Today's Volume | 12 548.00 |
Average Volume | 21 138.00 |
Market Cap | 17.83M |
EPS | $0 ( 2024-04-05 ) |
Next earnings date | ( $-2.89 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.360 |
ATR14 | $0.0920 (1.45%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-04 | Trachtenberg Eric | Buy | 4 600 | Common Stock |
2024-01-04 | Trachtenberg Eric | Sell | 1 227 | Common Stock |
2024-01-04 | Trachtenberg Eric | Buy | 20 500 | Stock Option (right to buy) |
2024-01-04 | Kharabi Darius | Buy | 4 600 | Common Stock |
2024-01-04 | Kharabi Darius | Sell | 1 385 | Common Stock |
INSIDER POWER |
---|
92.84 |
Last 100 transactions |
Buy: 1 301 269 | Sell: 48 062 |
Kala Pharmaceuticals Inc Correlation
10 Most Positive Correlations | |
---|---|
EOLS | 0.852 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Kala Pharmaceuticals Inc Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-303 000 (0.00 %) |
EPS: | $-17.35 |
Q4 | 2023 |
Revenue: | $70 000.00 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-3.18 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-157 000 (0.00 %) |
EPS: | $-3.41 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-77 000.00 (0.00 %) |
EPS: | $-4.36 |
Financial Reports:
No articles found.
Kala Pharmaceuticals Inc
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development products comprise KPI-287 that inhibits the vascular endothelial and platelet derived growth factors for the treatment of retinal diseases, including wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion; and selective glucocorticoid receptor modulators program, a novel class of compounds to regulate gene expression through the transrepression pathway while avoiding the transactivation pathway. The company was formerly known as Hanes Newco, Inc. and changed its name to Kala Pharmaceuticals, Inc. in December 2009. Kala Pharmaceuticals, Inc. was incorporated in 2009 and is headquartered in Watertown, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators